The Competition Commission of India (CCI) has approved pharma firm Mylan Laboratories’ acquiring Abbott Laboratories' Established Pharmaceutical Products (EPP) segment across Europe, Canada, Australia, New Zealand and Japan,saying the deal would not have an adverse impact on competition. Law Firm Luthra & Luthra acted on behalf of Mylan Inc. to get the approval.The Competition...